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Background: Falls are a ‘geriatric giant’ and are the third leading cause of chronic disability worldwide. About 30%
of community-dwellers over the age of 65 experience one or more falls every year leading to significant risk for
hospitalization, institutionalization, and even death. As the proportion of older adults increases, falls will place an
increasing demand and cost on the health care system. Exercise can effectively and efficiently reduce falls. Specifically,
the Otago Exercise Program has demonstrated benefit and cost-effectiveness for the primary prevention of falls in four
randomized trials of community-dwelling seniors. Although evidence is mounting, few studies have evaluated exercise
for secondary falls prevention (that is, preventing falls among those with a significant history of falls). Hence, we
propose a randomized controlled trial powered for falls that will, for the first time, assess the efficacy and efficiency of
the Otago Exercise Program for secondary falls prevention.
Methods/Design: A randomized controlled trial among 344 community-dwelling seniors aged 70 years and older
who attend a falls prevention clinic to assess the efficacy and the cost-effectiveness of a 12-month Otago Exercise
Program intervention as a secondary falls prevention strategy. Participants randomized to the control group will
continue to behave as they did prior to study enrolment. The economic evaluation will examine the incremental
costs and benefits generated by using the Otago Exercise Program intervention versus the control.
Discussion: The burden of falls is significant. The challenge is to make a difference – to discover effective, ideally
cost-effective, interventions that prevent injurious falls that can be readily translated to the population. Our proposal is
very practical – the exercise program requires minimal equipment, the physical therapist expertise is widely available,
and seniors in Canada and elsewhere have adopted the program and complied with it. Our innovation includes
applying the intervention to a targeted high-risk population, aiming to provide the best value for money. Given
society’s limited financial resources and the known and increasing burden of falls, there is an urgent need to test
this feasible intervention which would be eminently ready for roll out.
Trial registration: ClinicalTrials.gov Protocol Registration System: NCT01029171; registered 7 December 2009.
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Falls are a common geriatric syndrome [1] and are the third
leading cause of chronic disability worldwide [2]. Falls im-
pose significant risk for hospitalization, institutionalization,
and even death [3-5]. About 30% of community-dwellers
over the age of 65 experience one or more falls every year
[6], with half of these seniors experiencing recurrent falls.
With the proportion of older adults increasing, falls will
continue to place an increasing health and economic bur-
den on the public health system.
Exercise can effectively reduce falls. Specifically, New
Zealand researchers designed a physical therapist-delivered,
progressive home-based strength and balance training pro-
gram tailored for seniors [7-11]. This intervention – the
Otago Exercise Program (OEP) – has demonstrated benefit
in four randomized trials of community-dwelling seniors
selected based on age alone (that is, ≥ 80 years old) [7-11].
Only one of these four trials designated falls as the primary
outcome [12] while the others focused on measures of falls
risk. Hence, the OEP qualifies as primary falls prevention
(that is, preventing falls among those without a history of
falls). The Cochrane Collaboration [13] explicitly identifies
the OEP as the exercise training program with the strongest
evidence for falls prevention. Although the OEP is the exer-
cise training program with the strongest evidence for pri-
mary falls prevention [13], no randomized controlled trial
(RCT) powered for falls has evaluated the efficacy of the
OEP as a secondary falls prevention (that is, preventing falls
among those with a history of falls) strategy. Hence, a rigor-
ously designed RCT with falls as the primary outcome is an
essential next step to determine the role of OEP in prevent-
ing falls among senior men and women with a significant
history of falls. Previous research has demonstrated that the
best value for money of various falls prevention strategies
comes from targeting high-risk groups [14].
Improved physiological function is the generally ac-
cepted mechanism underlying the effectiveness of the
OEP in reducing falls [8]. However, in a meta-analysis
of four OEP randomized trials, falls were significantly
reduced by 35% while postural sway significantly im-
proved by only 9% and there was no significant im-
provement in knee extension strength [11]. Hence, the
OEP may reduce falls via mechanisms other than im-
proved physiological function. Specifically, we have dem-
onstrated proof-of-concept data suggesting that improved
cognitive function may be a very important mechanism by
which the OEP reduces falls [15].
Within the multiple domains of cognitive function, re-
duced executive functions are associated with falls [16-20].
Executive functions are higher order cognitive processes
that control, integrate, organize, and maintain other cogni-
tive abilities [21]. Executive functions decline substantially
with aging [22]. Importantly, reduced executive functions
are prevalent among healthy, community-dwelling seniorswith intact global cognitive function (that is, Mini-Mental
State Examination (MMSE) score ≥24/30) [23,24]. This
is not surprising given that many of the pathological
changes (for example, white matter lesions) associated
with reduced executive functions are prevalent but
clinically silent [25]. Our proof-of-concept study pro-
vided preliminary evidence that the OEP may improve
executive functions in senior fallers [15]. Given the
association between executive functions, exercise, and
falls, we hypothesize that improved executive functions
may be an important mechanism by which exercise re-
duces falls. However, this hypothesis is yet to be tested.
Furthermore, our proof-of-concept study did not have
the sample size to explore whether the observed change
in cognitive function was a mediator of the benefit of
the OEP.
Thus, we propose a 12-month RCT among community-
dwelling seniors aged 70 years and older who attend a
secondary falls prevention clinic to assess the efficacy and
the cost-effectiveness of the OEP as a secondary falls pre-
vention strategy. Further, we aim to explore the relative
importance of both physiological and cognitive factors
to falls reduction. Given the immense health and finan-
cial burden imposed by falls, our proposed RCT could
have significant impact on the health of Canadian seniors
and the Canadian health care system.
Methods
Design
We propose a RCT of 344 community-dwelling senior
with a history of falls (that is, one or more falls in the past
12 months), aged 70 and older. Participant randomized to
the OEP intervention group will receive the intervention
for 12-months. There will be three measurement sessions
with monthly monitoring (Figure 1).
Setting
All participants will be recruited from the Falls Prevention
Clinic at Vancouver General Hospital (www.fallclinic.
com).
Participants
All participants attending the Falls Prevention Clinic have
sustained one or more falls in the past 12 months. Referrals
to the Falls Prevention Clinic are from health care profes-
sionals (for example, physicians) for those who sought
medical attention for their fall. Patients who attend the
Falls Prevention Clinic receive falls risk factor assess-
ment followed by a comprehensive geriatric assessment.
The Falls Prevention Clinic care pathway is based on
the American Geriatrics Society/British Geriatrics Society/
American Academy of Orthopedic Surgeons Falls Pre-
vention Guidelines [26] (which is hereafter referred to
as “standard of care”).
3Figure 1 Overview of the flow of participants through the Action Seniors! trial.
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basis to identify eligible participants. Those who appear
eligible based on detailed chart review will be mailed an
information package and asked to call a research assist-
ant if they are interested in participating in the study.
When phone contact generates a person’s agreement to
participate, a research assistant will follow-up with a home
visit. During this home visit, the consent form will be
reviewed. Once written informed consent is obtained, the
research assistant will complete the baseline assessment.
Upon completion of the assessment, the research assist-
ant who will remain blinded to group allocation will
contact the research coordinator who will access the




1. Adults ≥70 years referred by a medical professional
to the Falls Prevention Clinic as a result of seekingmedical attention for a non-syncopal fall in the
previous 12 months
2. Understands, speaks, and reads English proficiently
3. MMSE [27] score ≥24/30
4. A Physiological Profile Assessment (PPA; Prince of
Wales Medical Research Institute, Sydney, Australia)
[28] score of at least 1.0 standard deviation above
age-normative value
or
Timed Up and Go (TUG) test [29] performance of
greater than 15 seconds
or
one additional non-syncopal fall in the previous
12 months
5. Expected to live greater than12 months (based on
the geriatricians’ expert opinion);
6. Living in the Greater Vancouver area
7. Community-dwelling (that is, not residing in a nursing
home, extended care unit, or assisted-care facility)
8. Able to walk 3 meters with or without an assistive device
9. Able to provide written informed consent
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1. Previously diagnosed with or suspected (by the
geriatrician) to have neurodegenerative disease
(for example. Parkinson’s disease)
2. Previously diagnosed with or suspected (by the
geriatrician) to have dementia (of any type)
3. Had a stroke
4. Have a history indicative of carotid sinus sensitivity
(that is, syncopal falls)
Ethical approval has been obtained from the Vancouver
Coastal Health Research Institute (V10-70171, 11 May
2004) and the University of British Columbia’s Clinical
Research Ethics Board (H04-70171, 11 May 2004).
Power calculation
The primary outcome is self-reported number of falls
over the 12-month follow-up period. The sample size
calculation employs a negative binomial regression
model [30] to account for the overdispersion typical of
falls data. Assuming an average fall rate in the control
group of 1.0 falls per year, an average follow-up of
0.9 years and an overdispersion parameter, φ, of 1.6, we
require 163 seniors per group to have 80% power to de-
tect a 35% relative reduction in fall rate (that is, 1.0
versus 0.65 falls per year). To accommodate a complete
loss to follow-up rate of 5% (that is, no fall diaries
returned) we will recruit a total of 344 seniors (that is,
172 per group). The estimate of the control fall rate
comes from the pooled analysis of four trials in a similar
population [11]. The estimate of the overdispersion
parameter comes from analysis of the data in Table two
of Shumway-Cook [31] which yields φ = 1.6. The esti-
mate for the average length of follow-up is based on our
previous proof-of-concept study conducted locally in the
same patient population in Greater Vancouver [15,32].
Only one of 74 participants returned no fall diaries so
our estimate of a 5% complete loss to follow-up rate is
conservative [32].
Measurements
Baseline measurements will be obtained prior to
randomization. There will be three measurement sessions:
baseline, 6 months, and 12 months.
Falls prevention clinic visit
The measurements listed below are acquired as part of
the Falls Prevention Clinic visit and will be collected as
the participants' baseline values upon informed consent.
Anthropometry Standing height is measured as stretch
stature to 0.1 cm per standard protocol. Weight will be
measured to 0.1 kg on a calibrated digital scale.Geriatrician examination All patients undergo a com-
prehensive geriatrician assessment based on the American
Geriatrics Society/British Geriatrics Society/American
Academy of Orthopedic Surgeons Falls Prevention Guide-
lines [26].
General health, falls history, and socioeconomic status
General health, falls history in the last 6 months [33], and
socioeconomic status are ascertained by questionnaires.
Global cognitive function Global cognitive function is
assessed using both the MMSE [27] and the Montreal
Cognitive Assessment (MoCA) [34]. The MoCA is a brief
30-point screening tool for mild cognitive impairment
[34] with high sensitivity and specificity. Specifically, it is
more sensitive than the MMSE in detecting mild cognitive
impairment. Using a cut-off score of 26, the MMSE had a
sensitivity of 18%, whereas the MoCA detected 90% of
individuals with mild cognitive impairment [34].
Balance and mobility General balance and mobility is
assessed with the: 1) Short Physical Performance Battery
[35]; and 2) the TUG test [29]. For the Short Physical
Performance Battery, participants are assessed on perfor-
mances of standing balance, walking, and sit-to-stand. Each
component is rated out of four points, for a maximum of
12 points. Poor performance on this scale predicts subse-
quent disability [35]. For the TUG test, participants are
instructed to rise from a standard chair, walk a distance of
3 meters, turn, walk back to the chair and sit down. A
TUG performance time of ≥13.5 seconds correctly classi-
fied persons as fallers in 90% of cases [36].
Physiological falls risk We use the PPA [28] to assess
physiological falls risk. The PPA is a valid and reliable
tool for falls risk assessment. Based on the performance
of five physiological domains (postural sway, hand reaction
time, quadriceps strength, proprioception, and edge con-
trast sensitivity), the PPA computes a falls risk score for
each individual and this measure has a 75% predictive
accuracy for falls in older people [28]. A PPA z-score of
0 to 1 indicates mild risk, 1 to 2 indicates moderate
risk, 2 to 3 indicates high risk, and 3 and above indi-
cates marked risk [37].
Mood We use the 15-item Geriatric Depression Scale
[38,39] to screen for depression. The Geriatric Depression
Scale specifically assesses for depressed mood in older
people and a score of 5 and greater indicates depres-
sion [39].
Co-morbidity The Functional Co-morbidity Index was
calculated to estimate the degree of co-morbidity associ-
ated with physical functioning [40].
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ton and Brody [41] Instrumental Activities of Daily Living
Scale screens for impaired instrumental activities of daily
living. This scale subjectively assesses ability to telephone,
shop, prepare food, housekeep, do laundry, handle fi-
nances, be responsible for taking medication, and deter-
mining mode of transportation.
Baseline home visit
The following additional measures will be acquired during
the home visit when written consent is obtained. The
maximum time lag between the baseline Falls Prevention
Clinic visit and the home visit is 1 month.
Falls-related self-efficacy Falls-related self-efficacy will
be assessed by the Activities-Specific Balance Confidence
(ABC) Scale. The 16-item ABC Scale [42] assesses falls-
related self-efficacy with each item rated from 0% (no
confidence) to 100% (complete confidence). The ABC
Scale score is correlated with other measures of self-
efficacy, distinguishes between individuals of low and high
mobility, and corresponds with balance performance
measures [43,44].
Physical activity level Current physical activity level
will be assessed by the valid and reliable Physical Activities
Scale for the Elderly questionnaire [45,46]. This 12-item
scale measures the average number of hours per day spent
participating in leisure, household, and occupational phys-
ical activities over the previous 7-day period.
Executive functions There is no unitary executive
function – rather, there are distinct processes. Thus,
no single measure of executive function can adequately
tap the construct in its entirety. Within the context of our
proposal, we refer to work by Miyake and colleagues [47]
who identified three key executive processes: 1) set shift-
ing; 2) updating (or working memory); and 3) selective
attention and conflict resolution (or response inhibition).
Set shifting requires one to go back and forth between
multiple tasks or mental sets [47]. Updating involves mon-
itoring incoming information for relevance to the task at
hand and then appropriately updating the informational
content by replacing old, no longer relevant information
with new incoming information. Conflict resolution
involves deliberately inhibiting dominant, automatic, or
prepotent responses. We will assess: 1) set shifting using
the Trail Making Test (Part A and B) [48]; 2) updating
(that is, working memory) using the verbal digits forward
and backward test [49]; and 3) response inhibition using
the Stroop Colour-Word Test [50]. These standardized
neuropsychological tests are sensitive to age- [48,51]
and intervention-related changes [52-56]. Information
processing speed will be indexed using the Digit SymbolSubstitution Test [57]. For this task, participants are first
presented with a series of numbers (1 to 9) and their cor-
responding symbols. They are asked to draw the correct
symbol for any digit placed randomly in pre-defined series
in 60 seconds. A higher number of correct answers in
this time period indicates better executive functions and
processing speed.
Verbal fluency Defined as the rate at which an individ-
ual can generate words, verbal fluency will be assessed
using both the FAS test (which assesses phonemic verbal
fluency) and the animal naming test (which assesses
semantic verbal fluency) [48]. For the FAS verbal fluency
test, participants will be asked to verbally generate as
many words (excluding proper names) as they can start-
ing with the letters “F”, “A” and “S”, each in 60 seconds
[48]. The total number of words generated for all three
letters will be used as the measure of performance. For
the animal naming test, participants will be asked to
generate a list of animal names in 60 seconds [48].
Health-related quality of life We will evaluate health-
related quality of life using Euro-Qol-5D three level
(EQ-5D-3 L) [58]. The EQ-5D ascertains health status
according to the following domains: mobility, self-care,
usual activities, pain, and anxiety/depression. We will
calculate quality-adjusted life years using the weightings
from each instrument to compare differences in the
incremental cost-effectiveness ratios.
Monthly measurement
The following measures will be collected monthly by
telephone: 1) current physical activity level as assessed by
the Physical Activities Scale for the Elderly questionnaire;
and 2) health-related quality of life as assessed by the
Short Form 6D [59], EuroQol EQ-5D-3 L [58], and Health
Utilities Index Mark 3 [60]. Strategies to promote adher-
ence to the OEP exercises during these monthly phone
calls will also occur.
Through monthly calendars and diaries, participants will
be asked to provide the following information: 1) falls and
adherence to the OEP (ascertainment of falls and ad-
herence to the OEP will be documented on monthly
calendars); and 2) health care resource utilization and
costs (participants will complete monthly health care
resource use diaries over the 12-month study period).
Randomization
Participants will be randomly assigned (1:1) to either the
OEP (plus standard of care) group or the standard of care
(control) group. The randomization sequence will be
stratified by: 1) sex, as falls rate is different between
men and women; and 2) geriatrician (LD and WC), as
standard of care delivery may differ between physicians.
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will be employed. To ensure concealment of the
treatment allocation, the randomization sequences will be
generated and held by a central Internet randomization
service.
Planned trial interventions
Otago Exercise Program intervention
The OEP is an individualized home-based balance
and strength retraining program [8,61]. It consists of
the following strengthening exercises: knee extensor
(4 levels), knee flexor (4 levels), hip abductor (4 levels),
ankle plantarflexors (2 levels), and ankle dorsiflexors
(2 levels). The balance retraining exercises consist of
the following: knee bends (4 levels), backwards walking
(2 levels), walking and turning around (2 levels),
sideways walking (2 levels), tandem stance (2 levels),
tandem walk (2 levels), one leg stand (3 levels), heel
walking (2 levels), toe walking (2 levels), heel toe walking
backwards (1 level), and sit to stand (4 levels).
Licensed physical therapists will deliver the OEP after
a standard training session with the research team. For
each OEP participant, a physical therapist will visit the
home and prescribe a set of suitable exercises from the
OEP manual. The same physical therapist will return
bi-weekly three additional times to make progressive
adjustments to the exercise protocol according to the
OEP manual. Each of these four visits in the first
2 months will take approximately 1 hour. The physical
therapist’s fifth visit will occur 6 months after the initial
visit. During this last visit, the physical therapist will
check that the OEP exercises are being done correctly
and will also encourage the participant to continue with
the exercise program. Overall, the participant is asked
to perform the OEP balance and strength retraining
exercises three times per week (approximately 30 minutes).
In addition to the OEP manual, which contains a picture
and description of each exercise, each participant will be
provided with an adjustable cuff weight (in 0.9 kg
increments; range = 0.9 to 9 kg) to be used with the
OEP strength training exercises. Based on data from
our proof-of-concept study [15], the OEP is safe for
our target population; only 2 of the 36 OEP participants
reported low back pain as adverse events.
Standard of care
Participants randomized to “standard of care” they receive
standard of care – visits with a geriatrician.
Adverse events monitoring
A physician and a statistician external to the daily activ-
ities of this study will review and compile a report for all
adverse events reported in the study on a monthly
basis. They will stop the study if the adverse event datademonstrate any hazards of the intervention (for example,
increased falls or fracture) based on the monthly report.
Statistical analyses
Our primary, secondary, and tertiary analyses will follow
the intention-to-treat principle (that is, all individuals will
be analyzed according to their group allocation regardless
of compliance).
Primary outcome
The rate of falls (the primary outcome) will be compared
between the two groups using a negative binomial re-
gression model. The treatment assignment and stratifica-
tion factors will be included in the model as covariates.
Point and interval estimates for the rate ratio will be
determined.
Secondary outcomes
We will conduct exploratory analyses on the secondary
outcomes (PPA, TUG test and Short Performance Physical
Battery). Given that a potential source of bias in this trial
will result from patients being unblinded to their group
allocation, group will be controlled for in all secondary
analyses.
Economic evaluation
Our economic evaluation will examine the incremen-
tal costs and benefits generated by using the OEP
intervention versus standard of care. The outcome of
our cost effectiveness analysis is the incremental
cost-effective ratio (ICER). By definition, an ICER is
the difference between the mean costs of providing
the competing interventions divided by the differ-
ence in effectiveness, where ICER = Δcost/Δeffect
[62]. Both a cost-effectiveness analysis and a cost
utility analysis will be performed. Based on the pri-
mary outcome of the RCT, we will determine the
incremental cost of the OEP intervention per fall
avoided, relative to standard treatment. We will also
conduct a cost-utility analysis. In a cost-utility ana-
lysis, the primary outcome is the quality-adjusted life
years. These are calculated based on the quality of
life of a patient (measured using health utilities) in a
given health state and the time spent in that health
state. An important aspect of economic evaluations
conducted alongside an RCT is how to deal with
missing data due to attrition. We will follow recom-
mendations by Oostenbrick and colleagues [63] and
Briggs and colleagues [64], and the International
Society for Pharmacoeconomics and Outcomes Research
[65], in dealing with missing cost and effectiveness
data. We will use a combination of imputation and
bootstrapping to quantify uncertainty due to missing
values.
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We will use path analysis – a special case of structural
equation modeling where all variables are observed –
to investigate how physiological function and cognitive
function mediate the effect of the intervention on
the primary outcome (that is, falls). Using Mplus 5.1
(www.statmodel.com) we will fit a negative binomial
regression model that includes one independent variable
and mediator variables.
Discussion
Our interdisciplinary research team will use a multi-
pronged approach to explore the utility of OEP among
seniors at high risk of future falls. The proposed trial may
have important public health, economic, and mechanistic
implications.
Public health
The simple and proven exercise program (that is, the
OEP) has already been implemented nationally in
New Zealand. Therefore, if our study demonstrates the
OEP is an efficacious and efficient (that is, cost-effective)
secondary falls prevention program, our findings could
be rolled out immediately by policy makers.
Economic
The parallel economic evaluation is particularly important
because, if the intervention proved to be cost-effective
compared with standard of care, it would provide a strong
argument for the OEP in the target population even at a
time of fiscal restraint. We highlight that this intervention,
the OEP, already has manuals, websites, and educational
material ready for a ‘turn-key’ operation.
Mechanistic
Better understanding of the primary mechanisms under-
lying the OEP (that is, our tertiary research objective)
would increase our capacity to refine and develop
novel interventions for secondary falls prevention for
the aging population. If improved executive functions
prove to play a significant role in falls reduction, it
would be a major contribution to knowledge in this
field.
Trial status
As of 1 December 2014 we have obtained ethical ap-
proval, have registered the trial and we have success-
fully recruited 227 participants. We will aim to
complete recruitment by 2017. One hundred and fifty
four patients have completed 6-month follow-up, 133
have completed 12-month follow-up and 26 partici-
pants have dropped out. The median number of par-
ticipation days for individuals who dropped out of the
study was 103.5.Abbreviations
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